ENZY — Enzymatica AB (publ) Cashflow Statement
0.000.00%
Last trade - 00:00- SEK604.41m
- SEK572.30m
- SEK53.90m
Annual cashflow statement for Enzymatica AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | Interim Report | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -45.2 | -68.2 | -48.1 | -52.1 | -51.4 |
| Depreciation | |||||
| Non-Cash Items | -1.3 | 7.2 | 0.256 | -1.73 | 5.76 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 4.05 | -4.43 | 1.01 | -12.5 | 4.64 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -35.9 | -65.4 | -40.3 | -60.5 | -41 |
| Capital Expenditures | -6.13 | -3.72 | -0.73 | -0.393 | -0.231 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -6.13 | -3.72 | -0.73 | -0.393 | -0.231 |
| Financing Cash Flow Items | -4.21 | -5.7 | 0 | -7.42 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 49.5 | 88.2 | -1.39 | 128 | -0.789 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 7.6 | 19.1 | -42.3 | 66.8 | -42.1 |